We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+2.72%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.67B
AUM Growth
-$8.92M
(-0.12%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
16.46%
Holding
1,176
New
399
Increased
225
Reduced
226
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$72.3M |
| 2 |
Medtronic
MDT
|
+$72.1M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$70.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$60M |
| 5 |
DD
Du Pont De Nemours E I
DD
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree India Earnings Fund ETF
EPI
|
+$121M |
| 2 |
American Airlines Group
AAL
|
+$75.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$68.5M |
| 4 |
Citizens Financial Group
CFG
|
+$67.7M |
| 5 |
AutoZone
AZO
|
+$65.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.85% |
| 2 | Financials | 15.2% |
| 3 | Communication Services | 14.25% |
| 4 | Technology | 10.35% |
| 5 | Materials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ionis Pharmaceuticals
IONS
$9.35B
| $8.59M | 0.11% |
+149,285
| New | +$9.49M |
|
202
Amazon
AMZN
$2.5T
| $8.57M | 0.11% |
395,060
+62,060
| +19% | +$1.3M |
|
|
SYNH
203
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $8.52M | 0.11% |
+212,390
| New | +$7.33M |
|
204
Halliburton
HAL
$27.9B
| $8.52M | 0.11% |
197,718
+157,367
| +390% | +$7.25M |
|
205
Amgen
AMGN
$203B
| $8.49M | 0.11% |
+55,277
| New | +$8.85M |
|
206
Everest Group
EG
$15.2B
| $8.46M | 0.11% |
46,509
+42,491
| +1,058% | +$7.73M |
|
|
MHFI
207
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $8.44M | 0.11% |
+84,016
| New | +$8.78M |
|
|
AVID
208
DELISTED
Avid Technology Inc
AVID
| $8.43M | 0.11% |
631,618
+343,931
| +120% | +$5.49M |
|
|
CTRX
209
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $8.42M | 0.11% |
137,876
+119,683
| +658% | +$7.18M |
|
210
Accenture
ACN
$89.9B
| $8.31M | 0.11% |
+85,849
| New | +$8.21M |
|
211
Cullen/Frost Bankers
CFR
$10.3B
| $8.3M | 0.11% |
+105,653
| New | +$7.8M |
|
212
Comscore
SCOR
| $8.23M | 0.11% |
+7,722
| New | +$8.33M |
|
213
Tenet Healthcare
THC
$20.1B
| $8.11M | 0.11% |
+140,180
| New | +$7.16M |
|
214
Agilent Technologies
A
$39.1B
| $8.1M | 0.11% |
+209,963
| New | +$8.72M |
|
215
HP
HPQ
$23.5B
| $8.07M | 0.11% |
592,014
-1,009,060
| -63% | -$15M |
|
216
Weyerhaeuser
WY
$17.3B
| $7.97M | 0.1% |
253,028
-612,982
| -71% | -$19.7M |
|
|
IDTI
217
DELISTED
Integrated Device Technology I
IDTI
| $7.96M | 0.1% |
366,813
-360,540
| -50% | -$7.78M |
|
218
RTX Corp
RTX
$287B
| $7.95M | 0.1% |
113,887
-407,426
| -78% | -$29.9M |
|
219
NETSCOUT
NTCT
$2.86B
| $7.95M | 0.1% |
+216,659
| New | +$8.89M |
|
220
SiriusXM
SIRI
$10B
| $7.88M | 0.1% |
211,351
+5,162
| +3% | +$200K |
|
221
TechnipFMC
FTI
$30.6B
| $7.82M | 0.1% |
+253,301
| New | +$7.79M |
|
222
Teva Pharmaceuticals
TEVA
$35.9B
| $7.82M | 0.1% |
132,299
+102,182
| +339% | +$6.3M |
|
|
SIX
223
DELISTED
Six Flags Entertainment Corp.
SIX
| $7.79M | 0.1% |
173,781
+131,995
| +316% | +$6.32M |
|
224
DHT Holdings
DHT
$2.97B
| $7.59M | 0.1% |
977,386
-197,988
| -17% | -$1.56M |
|
|
DRC
225
DELISTED
DRESSER-RAND GROUP INC
DRC
| $7.58M | 0.1% |
89,039
+3,783
| +4% | +$316K |
|
Similar funds
Marshall Wace's Q2 2015 Portfolio in Review
As of Q2 2015, Marshall Wace held 1,176 positions worth $7.67B, down 0.12% from $7.68B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace's Q2 2015 filing shows 399 new, 225 increased, 226 reduced and 299 closed positions. Its largest new stake was Du Pont De Nemours E I: 869,713 shares worth $52.8M. The largest sale was WisdomTree India Earnings Fund ETF, an estimated $121M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q2 2015 buy was Du Pont De Nemours E I: 869,713 shares worth $52.8M.
- Marshall Wace added most to Apple in Q2 2015, an estimated $72.3M increase.
- Marshall Wace's biggest Q2 2015 reduction was WisdomTree India Earnings Fund ETF, cutting an estimated $121M.
- Marshall Wace fully exited American Airlines Group in Q2 2015, selling an estimated $75.2M.
- Marshall Wace's ten largest holdings make up 16% of its $7.67B portfolio in Q2 2015.
- Marshall Wace opened 399 new positions and closed 299 in Q2 2015.
- Marshall Wace's portfolio value fell 0.12% quarter-over-quarter to $7.67B.
Based on Marshall Wace's 13F filing for Q2 2015, filed 14 Aug 2015.